Oncopeptides AB(DE:OND)
€0.16-0.01 (-4.88%)
DE:OND
Oncopeptides AB earnings date
€0.16
At close:-0.01 (-4.88%)
Oncopeptides AB (OND) Q3 2022 Earnings Report
6 Followers
DE:OND Q3 2022 EPS Results
- Actual EPS
- -EUR 0.06
- Consensus EPS
- -EUR 0.21
- Beat/Miss
- Beat by +EUR 0.15
- One Year Ago EPS
- -EUR 0.59
DE:OND Q3 2022 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 1.81M
- Beat/Miss
- Missed by -EUR 1.81M
- YoY Revenue Growth
- -100.00%
Earnings Announcement Details
- Quarter
- Q3 2022
- Date
- 11/09/2022
- Time
- Before Open
- Conference Call
- Wednesday, November 9, 2022
DE:OND Upcoming Earnings
Oncopeptides AB's next earnings date is estimated for February 18, 2027, based on past reporting schedules.
Q3 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:OND Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 18, 2027 | 2026 (Q4) | ―- | -0.02 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | ―-0.01 | -0.02 | 54.90% (+0.01) | |
| Aug 27, 2026 | 2026 (Q2) | ―-0.01 | -0.03 | 49.12% (+0.01) | |
| May 13, 2026 | 2026 (Q1) | ―-0.01 | -0.02 | 52.94% (+0.01) | |
| Feb 19, 2026 | 2025 (Q4) | -0.02-0.02 | -0.03 | 31.01% (+0.01) | |
| Nov 05, 2025 | 2025 (Q3) | -0.24-0.02 | -0.02 | 1.16% (+0.00) | |
| Aug 21, 2025 | 2025 (Q2) | ―-0.03 | -0.04 | 33.72% (+0.01) | |
| May 15, 2025 | 2025 (Q1) | ―-0.02 | -0.06 | 61.77% (+0.04) | |
| Feb 27, 2025 | 2024 (Q4) | ―-0.03 | -0.05 | 39.47% (+0.02) | |
| Nov 07, 2024 | 2024 (Q3) | ―-0.02 | -0.03 | 9.15% (+0.00) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
